Theerawit - Tasaneeyapan

Mr. Theerawit - Tasaneeyapan

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2024 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
KSKriengkrai Srithanaviboonchai
Kriengkrai Srithanaviboonchai
TYThitipong Yingyong
Thitipong Yingyong
TTTheerawit - Tasaneeyapan
Theerawit - Tasaneeyapan
SSSupaporn Suparak
Supaporn Suparak
SJSupiya Jantaramanee
Supiya Jantaramanee
SNSanny Chen Northbrook
Sanny Chen Northbrook
Background: A recent infection testing algorithm (RITA) incorporating case surveillance (CS) with the rapid test for recent HIV infection (RTRI) was integrated into HIV testing services in Thailand as a small-scale pilot project in October 2020. Objective: We aimed to describe the lessons learned and initial outcomes obtained after the establishment of the nationwide recent HIV infection surveillance project from April through August 2022. Methods: We conducted desk reviews, developed a surveillance protocol and manual, selected sites, trained staff, implemented surveillance, and analyzed outcomes. Remnant blood specimens of consenting newly diagnosed individuals were tested using the Asanté HIV-1 Rapid Recency Assay. The duration of HIV infection was classified as RTRI-recent or RTRI-long-term. Individuals testing RTRI-recent with CD4 counts 200 cells/mm3, no opportunistic infections, and not on antiretroviral treatment were classified as RITA-CS-recent. Results: Two hundred and one hospitals in 14 high-burden HIV provinces participated in the surveillance. Of these, 69 reported ≥1 HIV diagnosis during the surveillance period. Of 1053 newly diagnosed cases, 64 (6.1%) were classified as RITA-CS-recent. On multivariate analysis, self-reporting as transgender women (adjusted odds ratio [AOR] 7.41, 95% CI 1.59‐34.53) and men who have sex with men (AOR 2.59, 95% CI 1.02‐6.56) compared to heterosexual men, and students compared to office workers or employers (AOR 3.76, 95% CI 1.25‐11.35) were associated with RITA-CS-recent infection. The proper selection of surveillance sites, utilizing existing surveillance tools and systems, and conducting frequent follow-up and supervision visits were the most commonly cited lessons learned to inform the next surveillance phase. Conclusions: Recent HIV infection surveillance can provide an understanding of current epidemiologic trends to inform HIV prevention interventions to interrupt ongoing or recent HIV transmission. The key success factors of the HIV recent infection surveillance in Thailand include a thorough review of the existing HIV testing service delivery system, a streamlined workflow, strong laboratory and health services, and regular communication between sites and the Provincial Health Offices.

17 July 2025 in Viruses
Verified
Journal Article
Open access
PDF file
SSSupaporn Suparak
Supaporn Suparak
KNKanokwan Ngueanchanthong
Kanokwan Ngueanchanthong
PUPetai Unpol
Petai Unpol
SJSiriphailin Jomjunyoung
Siriphailin Jomjunyoung
WTWipawee Thanyacharern
Wipawee Thanyacharern
SNSanny Northbrook
Sanny Northbrook
Quality assurance programs are critical to ensuring the consistency and reliability of point-of-care surveillance test results. In 2022, we launched Laos’ inaugural quality control (QC) and external quality assessment (EQA) program for national HIV recent infection surveillance. Our study aims to implement the first QC and EQA program for national HIV recent infection surveillance in Laos, utilizing non-infectious dried tube specimens (DTS) for quality control testing. This initiative seeks to monitor and assure the quality of HIV infection surveillance. We employed the Asante HIV-1 Rapid Test for Recent Infection (HIV-1 RTRI) point-of-care kit, using plasma specimens from the Thai Red Cross Society to create dried tube specimens (DTS). The DTS panels, including HIV-1 negative, HIV-1 recent, and HIV-1 long-term samples, met ISO 13528:2022 standards to ensure homogeneity and stability. These panels were transported from the Thai National Institute of Health (Thai NIH) to the Laos National Center for Laboratory and Epidemiology (NCLE) and subsequently shipped to 12 remote laboratories at ambient temperature. The laboratory results were electronically transmitted to Thai NIH 15 days after receiving the panel for performance analysis. The concordance results with the sample types were scored, and laboratories that achieved 100% concordance across all sample panels were considered to have satisfactorily met the established standards. Almost all laboratories demonstrated satisfactory results with 100% concordance across all sample panels during all three rounds of QC: 11 out of 12 (92%) in June, 10 out of 12 (83%) in July, and 11 out of 12 (91%) in August. The two rounds of EQA performed in June and August 2022 were satisfied by 8 out of 11 (72%) and 5 out of 10 (50%) laboratories, respectively. QC and EQA monitoring identified errors such as testing protocol mistakes and insufficient DTS panel dissolution, leading to improvements in HIV recency testing quality. Laboratories that reported errors were corrected and implemented further preventive actions. The QC and EQA program for HIV-1 RTRI identified errors in HIV recent infection testing. Implementing a specialized QC and EQA program for DTS marks a significant advancement in improving the accuracy and consistency of HIV recent infection surveillance. Continuous assessment is vital for addressing recurring issues.

9 June 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
SSSupaporn Suparak
Supaporn Suparak
PUPetai Unpol
Petai Unpol
KNKanokwan Ngueanchanthong
Kanokwan Ngueanchanthong
SCSirilada Pimpa Chisholm
Sirilada Pimpa Chisholm
SJSiriphailin Jomjunyoung
Siriphailin Jomjunyoung
SNSanny Northbrook
Sanny Northbrook
The present study focuses on establishing the quality assurance of laboratories for recent infections (RTRI) in Thailand. We developed a cold-chain independent method, using fully characterized plasma obtained from the Thai Red Cross Society, and prepared as dried tube specimens (DTS). Twenty microliters of HIV-seronegative, recent, and long-term infected samples were aliquoted into individual tubes and dried at room temperature, 20–30 degrees Celsius, in a biosafety cabinet overnight to ensure optimal preservation. The DTS external quality control and external quality assessment were tested for homogeneity and stability following the ISO/Guide 35 guidelines. The DTS panels were distributed to 48 sites (FY 2022) and 27 sites (FY 2023) across 14 and 9 provinces, respectively, in Thailand. The results from participating laboratories were collected and evaluated for performance. The results were scored, and acceptable performance criteria were defined as the proportion of panels correctly tested, which was set at 100%. The satisfactory performance ranged from 96% to 100% and was not significantly different among the 13 health regions. The developed and implemented DTS panels can be used to monitor the quality of RTRI testing in Thailand.

13 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
SSSupaporn Suparak
Supaporn Suparak
TTTheerawit - Tasaneeyapan
Theerawit - Tasaneeyapan
PUPetai Unpol
Petai Unpol
SCSirilada Pimpa Chisholm
Sirilada Pimpa Chisholm
SJSiriphailin Jomjunyoung
Siriphailin Jomjunyoung
SNSanny Northbrook
Sanny Northbrook
Background: The World Health Organization and the Thailand National HIV Treatment Guidelines recommend the use of lateral flow urine lipoarabinomannan (LF-LAM) testing for tuberculosis (TB) detection in people living with HIV (PLHIV) with advanced HIV disease who have signs and symptoms of TB or are seriously ill. As Thailand decentralizes LF-LAM testing, a robust quality assurance system is needed to maintain diagnostic accuracy across healthcare levels. Methods: We developed, validated, and rolled out Thailand’s first national external quality assessment (EQA) and internal quality control (IQC) framework for urinary TB LF-LAM testing. Pre-characterized urine panels were distributed to 20 provinces spanning 12 health regions nationwide across four cycles from 2025 to 2026. Longitudinal monitoring of reporting compliance, pass rates, and failure modes was performed across 30 participating sites in 2025 and 64 and 42 sites in 2026 Rounds 1 and 2, respectively. Results: IQC coverage increased from 7 to 68 facilities by the final cycle in January 2026, with satisfaction rates of 85.7–100%. EQA pass rates showed a stepwise improvement: 83.3% in Round 1/2025, 93.1% in Round 2/2025 and 97.5% and 98.4% in the 2026 rounds (p < 0.05). Initial failures were primarily due to false-positive interpretation of Grade 1 bands and deviation in the reading window. Targeted retraining and standardized reference match-cards reduced user-dependent false-positive results to 0% in the final cycle. Conclusions: A centralized national quality assurance framework may be an effective mechanism for standardizing the reliability and interpretation of point-of-care LF-LAM testing across decentralized healthcare systems. This approach strengthens diagnostic capacity at peripheral facilities and supports the safe expansion of TB services for PLHIV.